CoChat

OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer

Open access
Saha, Biswajit, Mathur, Tanmay, Handley, Katelyn F., Hu, Wei, Afshar-Kharghan, Vahid, Sood, Anil K., Jain, Abhishek · 2020 · Blood Advances

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

In ovarian cancer, platelet extravasation into the tumor and resulting metastasis is thought to be regulated mostly by the vascular endothelium. Because it is difficult to dissect complex underlying events in murine models, organ-on-a-chip methodology is applied to model vascular and platelet functions in ovarian cancer. This system (OvCa-Chip) consists of microfluidic chambers that are lined by human ovarian tumor cells interfaced with a 3-dimensional endothelialized lumen. Subsequent perfusion with human platelets within the device's vascular endothelial compartment under microvascular shear conditions for 5 days uncovered organ-to-molecular-level contributions of the endothelium to triggering platelet extravasation into tumors. Further, analysis of effluents available from the device's individual tumor and endothelial chambers revealed temporal dynamics of vascular disintegration caused by cancer cells, a differential increase in cytokine expression, and an alteration of barrier maintenance genes in endothelial cells. These events, when analyzed within the device over time, made the vascular tissue leaky and promoted platelet extravasation. Atorvastatin treatment of the endothelial cells within the OvCa-Chip revealed improved endothelial barrier function, reduction in inflammatory cytokines and, eventually, arrest of platelet extravasation. These data were validated through corresponding observations in patient-derived tumor samples. The OvCa-Chip provides a novel in vitro dissectible platform to model the mechanisms of the cancer-vascular-hematology nexus and the analyses of potential therapeutics.

Overview

Integrity signals

Registry

Crossref · 10.1182/bloodadvances.2020001632

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 48 references

Cited by

See all 73

Metadata

Authors
Saha, B., Mathur, T., Handley, K. F., Hu, W., Afshar-Kharghan, V., Sood, A. K., & Jain, A.
Affiliations
  • Texas A&M University (US)
  • Department of Gynecologic Oncology and Reproductive Medicine and
  • Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX; and
  • Texas A&M Health Science Center (US)
Venue
Blood Advances
Published
2020-07-27
Volume
4
Issue
14
Pages
3329-3342
ISSN
  • 2473-9529 (ISSN-L)
  • 2473-9537
OpenAlex
W3045449149
Cited by
63
References
47
Citations by year
2026: 9 · 2025: 15 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 8
FWCI
2.36
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Blood Advances (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (P50CA217685, R35CA209904, R01CA177909, P30CA016672)
  • National Institute of Biomedical Imaging and Bioengineering (R21EB025945)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
ovarian cancer, organ-on-a-chip, vascular endothelium, tumor microvasculature, endothelial barrier function, vascular leakage, tumor inflammation, cytokines, atorvastatin, metastasis, microfluidic tumor model, platelet-endothelium interaction
MeSH terms
Animals, Blood Platelets, Endothelium, Vascular, Female, Humans, Ovarian Neoplasms, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer. https://app.cochat.ai/papers/10.1182/bloodadvances.2020001632
The paper
Saha, B., Mathur, T., Handley, K. F., Hu, W., Afshar-Kharghan, V., Sood, A. K., & Jain, A. (2020). OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer. Blood Advances. https://doi.org/10.1182/bloodadvances.2020001632

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.